Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinoma

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 813-818

  Liang, Zhe Long ^a,b   Kim, Meeran ^a   Huang, Song Mei ^a   Lee, Hyo Jin ^a   Kim, Jin Man ^a  

^a Chungnam National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Carboxyl terminus of Hsp70 interacting protein; Gallbladder carcinoma; Prognosis; Survival

Indexed keywords

HEAT SHOCK PROTEIN 70;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CARBOXY TERMINAL SEQUENCE; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; RISK FACTOR; TISSUE MICROARRAY;

EID: 84872694294     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1138     Document Type: Article

References (40)

1. Diehl AK: Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst 65: 1209-1214, 1980.
2. Randi G, Franceschi S and La Vecchia C: Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118: 1591-1602, 2006.
3. Miller G and Jarnagin WR: Gallbladder carcinoma. Euro J Surg Oncol 34: 306-312, 2008.
4. Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E and Salemis NS: Gallbladder cancer. Am J Surg 196: 252-264, 2008.
5. Balachandran P, Agarwal S, Krishnani N, et al: Predictors of long-term survival in patients with gallbladder cancer. JGastrointest Surg 10: 848-854, 2006.
6. Varga M, Obrist P, Schneeberger S, et al: Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10: 3131-3136, 2004.
7. Park JS, Yoon DS, Kim KS, et al: Analysis of prognostic factors after curative resection for gallbladder carcinoma. Korean J Gastroenterol 48: 32-36, 2006 (In Korean).
8. Malka D, Boige V, Dromain C, Debaere T, Pocard M and Ducreux M: Biliary tract neoplasms: update 2003. Curr Opin Oncol 16: 364-371, 2004.
9. Roa I, de Aretxabala X, Araya JC, et al: Morphological prognostic elements in gallbladder cancer. Rev Med Chil 130: 387-395, 2002 (In Spanish).
10. Roa I, Melo A, Roa J, Araya J, Villaseca M and de Aretxabala X: P53 gene mutation in gallbladder cancer. Rev Med Chil 128: 251-258, 2000 (In Spanish).
11. Itoi T, Watanabe H, Ajioka Y, et al: APC, K ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall bladder suggest two genetic pathways in gall bladder carcinogenesis. Pathol Int 46: 333-340, 1996.
12. Puhalla H, Wrba F, Kandioler D, et al: Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. Anticancer Res 27: 1679-1684, 2007.
13. Shi YZ, Hui AM, Li X, Takayama T and Makuuchi M: Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas. Clin Cancer Res 6: 4096-4100, 2000.
14. Zhi YH, Liu RS, Song MM, et al: Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 11: 3724-3728, 2005.
15. Giatromanolaki A, Sivridis E, Simopoulos C, et al: Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas. J Surg Oncol 94: 242-247, 2006.
16. Kim YW, Huh SH, Park YK, Yoon TY, Lee SM and HongSH: Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep 8: 1127-1132, 2001.
17. Zhang M, Pan JW, Ren TR, Zhu YF, Han YJ and Kühnel W: Correlated expression of inducible nitric oxide synthase and P53, Bax in benign and malignant diseased gallbladder. Ann Anat 185: 549-554, 2003.
18. Roa I, Ibacache G, Melo A, et al: Subserous gallbladder carcinoma: expression of cadherine-catenine complex. Rev Med Chil 130: 1349-1357, 2002 (In Spanish).
19. Chang HJ, Jee CD and Kim WH: Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 26: 758-766, 2002.
20. Choi YL, Xuan YH, Shin YK, et al: An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 52: 591-601, 2004.
21. Choi SY, Jo YS, Huang SM, et al: L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma. Hum Pathol 42: 1476-1483, 2011.
22. Connell P, Ballinger CA, Jiang J, et al: The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3: 93-96, 2001.
23. Demand J, Alberti S, Patterson C and Höhfeld J: Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr Biol 11: 1569-1577, 2001.
24. Zhou P, Fernandes N, Dodge IL, et al: ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 278: 13829-13837, 2003.
25. Luo W, Zhong J, Chang R, Hu H, Pandey A and Semenza GL: Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but not HIF-2α. JBiol Chem 285: 3651-3663, 2010.
26. Jang KW, Lee JE, Kim SY, et al: The C-terminus of Hsp70-interacting protein promotes Met receptor degradation. JThorac Oncol 6: 679-687, 2011.
27. Esser C, Scheffner M and Höhfeld J: The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem 280: 27443-27448, 2005.
28. Tripathi V, Ali A, Bhat R and Pati U: CHIP chaperones wild type p53 tumor suppressor protein. J Biol Chem 282: 28441-28454, 2007.
29. McDonough H, Charles PC, Hilliard EG, et al: Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program. JBiol Chem 284: 20649-20659, 2009.
30. Gao Y, Han C, Huang H, et al: Heat shock protein 70 together with its co-chaperone CHIP inhibits TNF-alpha induced apoptosis by promoting proteasomal degradation of apoptosis signal-regulating kinase1. Apoptosis 15: 822-833, 2010.
31. Li F, Xie P, Fan Y, et al: C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem 284: 20090-20098, 2009.
32. Xu T, Zhou Q, Zhou J, et al: Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci 102: 959-966, 2011.
33. Salvesen GS and Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401-410, 2002.
34. Haupt Y, Maya R, Kazaz A and Oren M: Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299, 1997.
35. Duan L, Miura Y, Dimri M, et al: Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. J Biol Chem 278: 28950-28960, 2003.
36. Harper JW, Burton JL and Solomon MJ: The anaphase-promoting complex: it's not just for mitosis any more. Genes Dev 16: 2179-2206, 2002.
37. Li SH, Li CF, Sung MT, et al: Skp2 is an independent prognosticator of gallbladder carcinoma among p27Kip1-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray. Mod Pathol 20: 497-507, 2007.
38. Lakshmanan M, Bughani U, Duraisamy S, Diwan M, Dastidar S and Ray A: Molecular targeting of E3 ligases-a therapeutic approach for cancer. Expert Opin Ther Targets 12: 855-870, 2008.
39. Sun Y: E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8: 645-654, 2006.
40. Kajiro M, Hirota R, Nakajima Y, et al: The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol 11: 312-319, 2009.